Abiopharma

🔍 BURKE JAMES R (Director)

Company: Solaris Energy Infrastructure, Inc. (SEI)

Report Date: 2026-08-23

Detailed Transactions and Holdings:

• Acquired 3,075 shares of Class A Common Stock (Direct)
  Date: 2026-08-23 | Code: A | equity_swap_involved: 0 | shares_owned_after: 8,771.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-08-23 | Code: H | nature_of_ownership: Spouse | shares_owned_after: 800.00
• Holds 0 shares of Class B Common Stock (Direct)
  Date: 2026-08-23 | Code: H | shares_owned_after: 42,734.00 | Footnotes: F3
• Holds 42,734 shares of Solaris Energy Infrastructure, LLC Units (Derivative)
  Date: 2026-08-23 | Code: H | shares_owned_after: 42,734.00 | Footnotes: F4, F4, F4

Footnotes:

• F1: Restricted Stock Award pursuant to the Solaris Energy Infrastructure, Inc. Long Term Incentive Plan. The award vests in full on the first anniversary of the grant date.
• F2: Includes 3,075 shares of Class A common stock subject to previously granted Restricted Stock Awards that remain subject to vesting.
• F3: Each share of Class B common stock has no economic rights but entitles the holder to one vote on all matters to be voted on by the stockholders generally.
• F4: Subject to the terms of the Second Amended and Restated Limited Liability Company Agreement of Solaris Energy Infrastructure, LLC ("Solaris LLC"), dated as of May 11, 2017, as amended from time to time, included as Exhibit 10.1 to the Issuer's Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission on May 17, 2017, the units in Solaris LLC (together with a corresponding number of shares of Class B common stock of the Issuer) are exchangeable from time to time for shares of Class A common stock of the Issuer.